218 related articles for article (PubMed ID: 38638139)
1. Phylogenetic and transcriptomic characterization of insulin and growth factor receptor tyrosine kinases in crustaceans.
Flores KA; Pérez-Moreno JL; Durica DS; Mykles DL
Front Endocrinol (Lausanne); 2024; 15():1379231. PubMed ID: 38638139
[TBL] [Abstract][Full Text] [Related]
2. Origin and molecular evolution of receptor tyrosine kinases with immunoglobulin-like domains.
Grassot J; Gouy M; Perrière G; Mouchiroud G
Mol Biol Evol; 2006 Jun; 23(6):1232-41. PubMed ID: 16551648
[TBL] [Abstract][Full Text] [Related]
3. Insulin and epidermal growth factor receptors contain the cysteine repeat motif found in the tumor necrosis factor receptor.
Ward CW; Hoyne PA; Flegg RH
Proteins; 1995 Jun; 22(2):141-53. PubMed ID: 7567962
[TBL] [Abstract][Full Text] [Related]
4. Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG.
Shimizu M; Shirakami Y; Moriwaki H
Int J Mol Sci; 2008 Jun; 9(6):1034-1049. PubMed ID: 19325845
[TBL] [Abstract][Full Text] [Related]
5. Systematic mapping of potential binding sites for Shc and Grb2 SH2 domains on insulin receptor substrate-1 and the receptors for insulin, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor.
Ward CW; Gough KH; Rashke M; Wan SS; Tribbick G; Wang J
J Biol Chem; 1996 Mar; 271(10):5603-9. PubMed ID: 8621421
[TBL] [Abstract][Full Text] [Related]
6. Receptor Tyrosine Kinases: Translocation Partners in Hematopoietic Disorders.
Nelson KN; Peiris MN; Meyer AN; Siari A; Donoghue DJ
Trends Mol Med; 2017 Jan; 23(1):59-79. PubMed ID: 27988109
[TBL] [Abstract][Full Text] [Related]
7. Parallels and Distinctions in FGFR, VEGFR, and EGFR Mechanisms of Transmembrane Signaling.
Sarabipour S
Biochemistry; 2017 Jun; 56(25):3159-3173. PubMed ID: 28621531
[TBL] [Abstract][Full Text] [Related]
8. Mapping ligand binding domains in chimeric fibroblast growth factor receptor molecules. Multiple regions determine ligand binding specificity.
Chellaiah A; Yuan W; Chellaiah M; Ornitz DM
J Biol Chem; 1999 Dec; 274(49):34785-94. PubMed ID: 10574949
[TBL] [Abstract][Full Text] [Related]
9. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors.
Ong SH; Guy GR; Hadari YR; Laks S; Gotoh N; Schlessinger J; Lax I
Mol Cell Biol; 2000 Feb; 20(3):979-89. PubMed ID: 10629055
[TBL] [Abstract][Full Text] [Related]
10. Monitoring activities of receptor tyrosine kinases using a universal adapter in genetically encoded split TEV assays.
Wintgens JP; Wichert SP; Popovic L; Rossner MJ; Wehr MC
Cell Mol Life Sci; 2019 Mar; 76(6):1185-1199. PubMed ID: 30623207
[TBL] [Abstract][Full Text] [Related]
11. VEGFR and type-V RTK activation and signaling.
Shibuya M
Cold Spring Harb Perspect Biol; 2013 Oct; 5(10):a009092. PubMed ID: 24086040
[TBL] [Abstract][Full Text] [Related]
12. Receptor tyrosine kinases fall into distinct classes based on their inferred signaling networks.
Wagner JP; Wolf-Yadlin A; Sevecka M; Grenier JK; Root DE; Lauffenburger DA; MacBeath G
Sci Signal; 2013 Jul; 6(284):ra58. PubMed ID: 23861540
[TBL] [Abstract][Full Text] [Related]
13. The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells.
Cross MJ; Lu L; Magnusson P; Nyqvist D; Holmqvist K; Welsh M; Claesson-Welsh L
Mol Biol Cell; 2002 Aug; 13(8):2881-93. PubMed ID: 12181353
[TBL] [Abstract][Full Text] [Related]
14. Gene structure and function of tyrosine kinases in the marine sponge Geodia cydonium: autapomorphic characters in Metazoa.
Müller WE; Kruse M; Blumbach B; Skorokhod A; Müller IM
Gene; 1999 Sep; 238(1):179-93. PubMed ID: 10570996
[TBL] [Abstract][Full Text] [Related]
15. Conserved roles for receptor tyrosine kinase extracellular regions in regulating receptor and pathway activity.
Gonzalez-Magaldi M; McCabe JM; Cartwright HN; Sun N; Leahy DJ
Biochem J; 2020 Nov; 477(21):4207-4220. PubMed ID: 33043983
[TBL] [Abstract][Full Text] [Related]
16. The receptor AXL diversifies EGFR signaling and limits the response to EGFR-targeted inhibitors in triple-negative breast cancer cells.
Meyer AS; Miller MA; Gertler FB; Lauffenburger DA
Sci Signal; 2013 Aug; 6(287):ra66. PubMed ID: 23921085
[TBL] [Abstract][Full Text] [Related]
17. Quantifying the strength of heterointeractions among receptor tyrosine kinases from different subfamilies: Implications for cell signaling.
Paul MD; Grubb HN; Hristova K
J Biol Chem; 2020 Jul; 295(29):9917-9933. PubMed ID: 32467228
[TBL] [Abstract][Full Text] [Related]
18. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in nitrogen-containing heterocyclic compounds as receptor tyrosine kinase inhibitors for the treatment of cancer: Biological activity and structural activity relationship.
Taruneshwar Jha K; Shome A; Chahat ; Chawla PA
Bioorg Chem; 2023 Sep; 138():106680. PubMed ID: 37336103
[TBL] [Abstract][Full Text] [Related]
20. Delta opioid activation of the mitogen-activated protein kinase cascade does not require transphosphorylation of receptor tyrosine kinases.
Kramer HK; Onoprishvili I; Andria ML; Hanna K; Sheinkman K; Haddad LB; Simon EJ
BMC Pharmacol; 2002; 2():5. PubMed ID: 11897012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
